BACKGROUND: Perinatally HIV-infected (PHIV) children may be at risk of undervaccination. Vaccination coverage rates among PHIV and HIV-exposed uninfected (HEU) children in Latin America and the Caribbean were compared. METHODS: All PHIV and HEU children born from 2002 to 2007 who were enrolled in a multisite observational study conducted in Latin America and the Caribbean were included in this analysis. Children were classified as up to date if they had received the recommended number of doses of each vaccine at the appropriate intervals by 12 and 24 months of age. Fisher's exact test was used to analyze the data. Covariates potentially associated with a child's HIV status were considered in multivariable logistic regression modeling. RESULTS: Of 1156 eligible children, 768 (66.4%) were HEU and 388 (33.6%) were PHIV. HEU children were significantly (P < 0.01) more likely to be up to date by 12 and 24 months of age for all vaccines examined. Statistically significant differences persisted when the analyses were limited to children enrolled before 12 months of age. Controlling for birth weight, sex, primary caregiver education and any use of tobacco, alcohol or illegal drugs during pregnancy did not contribute significantly to the logistic regression models. CONCLUSIONS: PHIV children were significantly less likely than HEU children to be up to date for their childhood vaccinations at 12 and 24 months of age, even when limited to children enrolled before 12 months of age. Strategies to increase vaccination rates in PHIV are needed.
BACKGROUND: Perinatally HIV-infected (PHIV) children may be at risk of undervaccination. Vaccination coverage rates among PHIV and HIV-exposed uninfected (HEU) children in Latin America and the Caribbean were compared. METHODS: All PHIV and HEU children born from 2002 to 2007 who were enrolled in a multisite observational study conducted in Latin America and the Caribbean were included in this analysis. Children were classified as up to date if they had received the recommended number of doses of each vaccine at the appropriate intervals by 12 and 24 months of age. Fisher's exact test was used to analyze the data. Covariates potentially associated with a child's HIV status were considered in multivariable logistic regression modeling. RESULTS: Of 1156 eligible children, 768 (66.4%) were HEU and 388 (33.6%) were PHIV. HEU children were significantly (P < 0.01) more likely to be up to date by 12 and 24 months of age for all vaccines examined. Statistically significant differences persisted when the analyses were limited to children enrolled before 12 months of age. Controlling for birth weight, sex, primary caregiver education and any use of tobacco, alcohol or illegal drugs during pregnancy did not contribute significantly to the logistic regression models. CONCLUSIONS: PHIV children were significantly less likely than HEU children to be up to date for their childhood vaccinations at 12 and 24 months of age, even when limited to children enrolled before 12 months of age. Strategies to increase vaccination rates in PHIV are needed.
Authors: Rosanna W Setse; Felicity Cutts; Mwaka Monze; Judith J Ryon; Thomas C Quinn; Diane E Griffin; William J Moss Journal: J Trop Pediatr Date: 2006-01-09 Impact factor: 1.165
Authors: A C Hesseling; L F Johnson; H Jaspan; M F Cotton; A Whitelaw; H S Schaaf; P E M Fine; B S Eley; B J Marais; J Nuttall; N Beyers; P Godfrey-Faussett Journal: Bull World Health Organ Date: 2009-07 Impact factor: 9.408
Authors: Anthony Burton; Roeland Monasch; Barbara Lautenbach; Marta Gacic-Dobo; Maryanne Neill; Rouslan Karimov; Lara Wolfson; Gareth Jones; Maureen Birmingham Journal: Bull World Health Organ Date: 2009-07 Impact factor: 9.408
Authors: Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke Journal: MMWR Recomm Rep Date: 2009-09-04
Authors: Andrea L Ciaranello; Yuchiao Chang; Andrea V Margulis; Adam Bernstein; Ingrid V Bassett; Elena Losina; Rochelle P Walensky Journal: Clin Infect Dis Date: 2009-12-15 Impact factor: 9.079
Authors: James Ndirangu; Till Bärnighausen; Frank Tanser; Khin Tint; Marie-Louise Newell Journal: Trop Med Int Health Date: 2009-09-07 Impact factor: 2.622
Authors: George K Siberry; Kunjal Patel; William J Bellini; Brad Karalius; Murli U Purswani; Sandra K Burchett; William A Meyer; Sun Bae Sowers; Angela Ellis; Russell B Van Dyke Journal: Clin Infect Dis Date: 2015-06-09 Impact factor: 9.079
Authors: Regina C M Succi; Margot R Krauss; D Robert Harris; Daisy M Machado; Maria I de Moraes-Pinto; Marisa M Mussi-Pinhata; Noris Pavia Ruz; Russell B Pierre; Lenka A Kolevic Roca; Esaú Joao; Irene Foradori; Marcelo C Scotta; Rohan Hazra; George K Siberry Journal: Pediatr Infect Dis J Date: 2018-04 Impact factor: 2.129